G. Marandi, N. Hazeri, M. T. Maghsoodlon, S. M. Habibi-Khorassani, N. A. Torbati,
F. Rostami-Charati, B. W. Skelton, and M. Makha
Vol 000
d, J=7.5Hz, Ar-H), 7.05 (1H, d, J=8.2Hz, CHchlorophen), 7.11 (1H,
t, J=7.9Hz, CHchlorophen), 7.36 (1H, t, J=7.6Hz, C5-H), 7.40 (1H,
br s, C6-H), 7.46 (1H, d, J=8.9Hz, C7-H), 7.61 (1H, dd, J1 =4.2,
J2 =8.1Hz, C3-H), 7.88 (1H, d, J=8.9Hz, C8-H), 7.91 (2H, br s,
2 CHchlorophen), 8.38 (1H, dd, J1 =1.5, J2 =8.1Hz, C4-H), 8.49
(1H, br s, NH), 9.12 (1H, dd, J1 =1.5, J2 =4.2Hz,
C2-H). 13C NMR (125.8 MHz, CDCl3): 18.0 (ArMe2), 83.7 (C9),
116.2 (-CN), 118.3, 120.6 (2 CHphen), 121.4 and 121.8
(2 CHchlorophen), 125.5 (CHaryl), 126.3 and 126.6 (2 CHphen), 127.0
(C10), 127.7 (CHphen), 128.2 (Cphen), 128.3 (2 CHaryl and
CHchlorophen), 128.6 (CHphen), 129.1 (Cphen), 133.1 (2 Caryl), 133.1 and
133.9 (2 Cphen), 136.2 and 137.2 (2 Cchlorophen), 139.4 (C11), 140.2
(Caryl), 147.9 and 150.1 (Cphen and CHphen).
11-(Cyclohexylamino)-10-(4-nitrophenyl)H-pyrrolo[1,2-a]
[1,10]phenanthroline-9-carbonitrile (5c). Pale white crystals;
(0.43 g), yield 94%; mp 236–239ꢀC. IR (KBr) (nmax, cmÀ1): 3213
(NH), 2209 (CN), 1662 (C═N). MS, m/z (%)= 462 (M+ + 1, 14),
461 (M+, 44), 378 (87), 331 (45), 306 (7), 180 (100), 98 (6), 83
(12), 55 (21), 41 (14). Anal. Calcd for C28H23N5O2 (461.51):
C, 72.87; H, 5.02; N, 15.17. Found: C, 72.93; H, 5.07; N, 15.09.
1H NMR (500.1MHz, CDCl3): 0.54–1.24 (10H, m, 5 CH2 of
cyclohexyl), 2.25 (1H, m, NCH of cyclohexyl), 7.46 (1H, d,
J = 8.9 Hz, C5-H), 7.64 (1H, dd, J1 = 4.2, J2 = 7.9 Hz, C3-H), 7.84
(1H, d, J = 8.9 Hz, C6-H), 7.89 (1H, d, J = 8.5 Hz, C7-H), 7.92
(1H, d, J = 8.5 Hz, CHnitrophen), 8.29 (1H, d, J = 8.5 Hz, C8-H),
8.31–8.39 (3H, m, 3 CHnitrophen), 8.42 (1H, dd, J1 = 1.7,
J2 = 7.9 Hz, C4-H), 9.13 (1H, dd, J1 = 1.7, J2 = 4.2 Hz, C2-H), 9.18
(1H, br s, NH). 13C NMR (125.8 MHz, CDCl3): 24.2, 25.4, 33.4
and 57.1 (5 CH2 and HNC of cyclohexyl), 83.8 (C9), 116.8
(-CN), 118.6, 121.2 (2 CHphen), 123.1 (CHphen), 123.7
(2 CHnitrophen), 125.8 (CHphen), 126.2 (Cphen), 127.5 (CHphen), 128.2
(C10), 129.7 (CHphen), 130.1, 136.1 and 137.1 (2 Cphen), 137.4
(2 CHnitrophen), 139.6 (Cnitrophen), 140.7 (C11), 146.4 (Cnitrophen),
147.9 and 150.1 (Cphen and CHphen).
11-(Cyclohexylamino)-10-(p-tolyl)pyrrolo[1,2-a][1,10]
phenanthroline-9-carbonitrile (5d). Red crystals; (0.42 g), yield
93%; mp 167–170ꢀC. IR (KBr) (nmax, cmÀ1): 3373 (NH), 2204
(CN), 1649 (C═N). MS, m/z (%) = 431 (M+ + 1, 6), 430 (M+, 20),
347 (77), 180 (100), 154 (18), 119 (18), 83 (13), 55 (25), 41 (19).
Anal. Calcd for C29H26N4 (430.54): C, 80.90; H, 6.09; N, 13.01.
Found: C, 80.96; H, 5.98; N, 12.93. 1H NMR (500.1 MHz,
CDCl3): 0.55–1.28 (10H, m, 5 CH2 of cyclohexyl), 2.28 (1H,
m, NCH of cyclohexyl), 2.31 (3H, s, CH3), 6.07 (1H, br s, NH),
7.32 (2H, d, J=8.0Hz, 2 CHtolyl), 7.41 (1H, d, J=8.9Hz, C5-H),
7.60 (1H, dd, J1 =4.3, J2 =8.1Hz, C3-H), 7.85 (1H, d, J=8.9Hz,
C6-H), 7.87 (2H, br s, C7-H, C8-H), 7.87 (2H, d, J =8.0Hz, 2
CHtolyl), 8.38 (1H, dd, J1 =1.8, J2 =8.1Hz, C4-H), 9.12 (1H, dd,
J1 =1.8, J2 =4.3Hz, C2-H). 13C NMR (125.8 MHz, CDCl3): 21.2
(CH3), 24.1, 25.4, 33.2 and 56.0 (5 CH2 and HNC of cyclohexyl),
84.4 (C9), 117.2 (-CN), 118.5, 120.7 (2 CHphen), 121.5 and 125.0
(2 CHphen), 127.3 (CHphen), 127.9 (Ctolyl), 128.8 (Cphen), 128.9 and
129.2 (4 CHtolyl), 129.9 (C10), 130.4 (Cphen), 136.2 (Ctolyl), 136.8
(C11), 136.9 (CHphen), 137.2 (Cphen), 139.8 (Cphen), 147.5 and
150.2 (CHphen and Cphen).
NCH of cyclohexyl), 6.18 (1H, br s, NH), 7.26 (1H, t, J=5.8Hz,
CHfluorophen), 7.30 (1H, t, J=7.5Hz, CHfluorophen), 7.40 (1H, m,
CHfluorophen), 7.42 (1H, d, J =8.9Hz, C8-H), 7.63 (1H, dd, J1 =4.2,
J2 =8.1Hz, C3-H), 7.79 (1H, dt, J1 =1.9, J2 =7.9Hz, CHfluorophen),
7.85 (1H, d, J=8.9Hz, C7-H), 7.88 (2H, br s, C5-H and C6-H),
8.38 (1H, dd, J1 =1.5, J2 =8.1Hz, C4-H), 9.10 (1H, dd, J1 =1.5,
J2 =4.2Hz, C2-H). 13C NMR (125.8 MHz, CDCl3): 24.1, 25.4,
33.2 and 55.7 (5 CH2 and HNC of cyclohexyl), 85.9 (C9), 115.8
(d, JCF =13.2Hz, CHfluorophen), 116.0 (-CN), 118.6, 120.7 (2
CHphen), 121.4 (d, JCF =15.1 Hz, Cfluorophen), 122.9 (Cphen), 123.8
(d, JCF =3.4Hz, CHfluorophen), 125.2 (CHphen), 126.4 (Cphen), 127.2
(CHphen), 127.9 (CHphen), 128.8 (C10), 129.3 (d, JCF =7.9Hz,
CHfluorophen), 129.9 (Cphen), 135.9 (d, JCF =6.8Hz, CHfluorophen),
138.1 (Cphen), 138.7 (C11), 138.9 (CHphen), 147.6 and 150.1
(CHphen and Cphen), 160.3 (d, JCF = 248.4 Hz, CHfluorophen).
Crystal refinement details for compound 5b. C30H21ClN4,
M= 472.96, F(000) = 492, triclinic, P1, Z=2, T=100(2)K,
a= 8.1485(6), b= 12.1418(10), c= 12.2529(9) Å, a = 77.113(7),
b = 85.161(6), g = 74.723(7)ꢀ, V = 1139.56(15) Å3; Dc =
1.378 g cmÀ3
;
m
Mo = 0.196 mmÀ1
;
θ
max = 28.7ꢀ; R1 (I > 2s
(I)) = 0.0444, wR2 (all data) = 0.0870, GOF = 0.864; |Δrmax| =
0.31e ÅÀ3. Crystallographic data were collected at 100(2) K on an
Oxford Diffraction Xcalibur diffractometer (Oxford Diffraction,
Oxford, UK) fitted with graphite-monochromated Mo Ka
radiation yielding 9062 reflections, these merging to 5049 unique
after multiscan absorption corrections (Rint = 0.0339), with
2889 reflections having I > 2s(I). The structure was refined
against F2 with full-matrix least-squares using the program
SHELXL-97 [25]. All H atoms were added at calculated positions
and refined by use of a riding model with isotropic displacement
parameters based on that of the parent atom. Anisotropic
displacement parameters were employed throughout for the
nonhydrogen atoms. The Ph ring 18n is rotationally disordered
about the C181-C184 line resulting in the Cl atom being
disordered over the 3-position and 5-position with occupancies
refined to 0.655(1) and its complement for the two sites. The
crystal structure for 5b is depicted in Figure 1 where ellipsoids
have been drawn at the 50% probability level. CCDC number
745666 contains the crystallographic data for compound 5b.
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax:
(internat.) +44-1223/336-033; Email: deposit@ccdc.cam.ac.uk.
Acknowledgments. We gratefully acknowledge the financial
support of the Research Council of the University of Sistan and
Baluchestan.
REFERENCES AND NOTES
[1] Chai, W.; Breitenbucher, J. G. Bioorg Med Chem 2003, 11, 1767.
[2] Goff, D. A. Tetrahedron Lett 1999, 40, 8741.
[3] Gundersen, L. L.; Malterud, K. E.; Negussie, A. H.; Rise, F.;
Teklu, S.; ꢀstby, O. B. Bioorg Med Chem 2003, 11, 5409.
[4] Bora, U.; Saikia, A.; Boruah, R. C. Org Lett 2003, 5, 435.
[5] Wiench, J. W.; Stefaniak, L.; Webb, G. A. J Mol Structure
2002, 605, 33.
[6] Li, Y.; Hu, H. Y.; Ye, J. P. J Org Chem 2004, 69, 2332.
[7] Izuddin-Nasir, A.; Gundersen, L. L.; Rise, F.; Antonsen, ꢀ.;
Kristensen, T.; Langhelle, B.; Bast, A.; Custers, I.; Haenen, G. R. M.
M.; Wikström, H. Bioorg Med Chem Lett 1998, 8, 1829.
11-(Cyclohexylamino)-10-(2-fluorophenyl)pyrrolo[1,2-a][1,10]
phenanthroline-9-carbonitrile (5e). Light red crystals; (0.42 g),
yield 96%; mp 146–149ꢀC. IR (KBr) (nmax, cmÀ1): 3417 (NH),
2204 (CN), 1656 (C═N). MS, m/z (%) = 435 (M+ +1, 9), 434 (M+,
28), 351 (100), 324 (7), 180 (64), 83 (6), 55 (15), 41 (12). Anal.
Calcd for C28H23FN4 (434.51): C, 77.40; H, 5.34; N, 12.89.
Found: C, 77.54; H, 5.29; N, 12.77. 1H NMR (500.1 MHz,
CDCl3): 0.55–1.24 (10H, m, 5 CH2 of cyclohexyl), 2.27 (1H, m,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet